Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Anti-obesity drug discovery: advances and challengesNature reviews. Drug discovery, 2022-03, Vol.21 (3), p.201-223 [Peer Reviewed Journal]2021. Springer Nature Limited. ;Springer Nature Limited 2021 ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/s41573-021-00337-8 ;PMID: 34815532Full text available |
|
2 |
Material Type: Article
|
Pharmacological Management of Obesity: An Endocrine Society Clinical Practice GuidelineThe journal of clinical endocrinology and metabolism, 2015-02, Vol.100 (2), p.342-362 [Peer Reviewed Journal]Copyright © 2015 by the Endocrine Society ;Copyright © 2015 by The Endocrine Society ;ISSN: 0021-972X ;EISSN: 1945-7197 ;DOI: 10.1210/jc.2014-3415 ;PMID: 25590212Full text available |
|
3 |
Material Type: Article
|
A Dozen Years of Discovery: Insights into the Physiology and Pharmacology of FGF21Cell metabolism, 2019-02, Vol.29 (2), p.246-253 [Peer Reviewed Journal]2019 Elsevier Inc. ;Copyright © 2019 Elsevier Inc. All rights reserved. ;ISSN: 1550-4131 ;EISSN: 1932-7420 ;DOI: 10.1016/j.cmet.2019.01.004 ;PMID: 30726758Full text available |
|
4 |
Material Type: Article
|
Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for ManagementCirculation (New York, N.Y.), 2018-03, Vol.137 (13), p.1391-1406 [Peer Reviewed Journal]2018 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2018 American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.117.029617 ;PMID: 29581366Full text available |
|
5 |
Material Type: Article
|
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Diabetes care, 2018-12, Vol.41 (12), p.2669-2701 [Peer Reviewed Journal]2018 American Diabetes Association and European Association for the Study of Diabetes. ;Copyright American Diabetes Association Dec 1, 2018 ;2018 American Diabetes Association and European Association for the Study of Diabetes. 2018 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dci18-0033 ;PMID: 30291106Full text available |
|
6 |
Material Type: Article
|
Tirzepatide Once Weekly for the Treatment of ObesityThe New England journal of medicine, 2022-07, Vol.387 (3), p.205-216 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2206038 ;PMID: 35658024Full text available |
|
7 |
Material Type: Article
|
Comprehensive Review in Current Developments of Imidazole‐Based Medicinal ChemistryMedicinal research reviews, 2014-03, Vol.34 (2), p.340-437 [Peer Reviewed Journal]2013 Wiley Periodicals, Inc. ;ISSN: 0198-6325 ;EISSN: 1098-1128 ;DOI: 10.1002/med.21290 ;PMID: 23740514 ;CODEN: MRREDDFull text available |
|
8 |
Material Type: Article
|
Once-Weekly Semaglutide in Adults with Overweight or ObesityThe New England journal of medicine, 2021-03, Vol.384 (11), p.989-1002 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2032183 ;PMID: 33567185Full text available |
|
9 |
Material Type: Article
|
Targeting adipose tissue in the treatment of obesity-associated diabetesNature reviews. Drug discovery, 2016-09, Vol.15 (9), p.639-660 [Peer Reviewed Journal]Copyright Nature Publishing Group Sep 2016 ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/nrd.2016.75 ;PMID: 27256476Full text available |
|
10 |
Material Type: Article
|
Unimolecular Polypharmacy for Treatment of Diabetes and ObesityCell metabolism, 2016-07, Vol.24 (1), p.51-62 [Peer Reviewed Journal]2016 Elsevier Inc. ;Copyright © 2016 Elsevier Inc. All rights reserved. ;ISSN: 1550-4131 ;EISSN: 1932-7420 ;DOI: 10.1016/j.cmet.2016.06.021 ;PMID: 27411008Full text available |
|
11 |
Material Type: Article
|
Treatment of Obesity with CelastrolCell, 2015-05, Vol.161 (5), p.999-1011 [Peer Reviewed Journal]2015 Elsevier Inc. ;Copyright © 2015 Elsevier Inc. All rights reserved. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2015.05.011 ;PMID: 26000480Full text available |
|
12 |
Material Type: Article
|
A Randomized, Controlled Trial of Liraglutide for Adolescents with ObesityThe New England journal of medicine, 2020-05, Vol.382 (22), p.2117-2128 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1916038 ;PMID: 32233338Full text available |
|
13 |
Material Type: Article
|
The Science of Obesity Management: An Endocrine Society Scientific StatementEndocrine reviews, 2018-04, Vol.39 (2), p.79-132 [Peer Reviewed Journal]Copyright © 2018 Endocrine Society 2018 ;Copyright © Oxford University Press 2015 ;COPYRIGHT 2018 Oxford University Press ;Copyright © 2018 Endocrine Society ;ISSN: 0163-769X ;EISSN: 1945-7189 ;DOI: 10.1210/er.2017-00253 ;PMID: 29518206Full text available |
|
14 |
Material Type: Article
|
Activation of Human Brown Adipose Tissue by a β3-Adrenergic Receptor AgonistCell metabolism, 2015-01, Vol.21 (1), p.33-38 [Peer Reviewed Journal]2015 Elsevier Inc. ;Copyright © 2015 Elsevier Inc. All rights reserved. ;2015 Elsevier Inc. 2015 ;ISSN: 1550-4131 ;EISSN: 1932-7420 ;DOI: 10.1016/j.cmet.2014.12.009 ;PMID: 25565203Full text available |
|
15 |
Material Type: Article
|
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trialNature medicine, 2022-10, Vol.28 (10), p.2083-2091 [Peer Reviewed Journal]2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-022-02026-4 ;PMID: 36216945Full text available |
|
16 |
Material Type: Article
|
Physical activity enhances the improvement of body mass index and metabolism by inulin: a multicenter randomized placebo-controlled trial performed in obese individualsBMC medicine, 2022-03, Vol.20 (1), p.110-110, Article 110 [Peer Reviewed Journal]2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;The Author(s) 2022 ;ISSN: 1741-7015 ;EISSN: 1741-7015 ;DOI: 10.1186/s12916-022-02299-z ;PMID: 35351144Full text available |
|
17 |
Material Type: Article
|
Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trialsThe Lancet (British edition), 2022-01, Vol.399 (10321), p.259-269 [Peer Reviewed Journal]Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01640-8 ;PMID: 34895470Full text available |
|
18 |
Material Type: Article
|
Glucose-Dependent Insulinotropic Polypeptide Receptor-Expressing Cells in the Hypothalamus Regulate Food IntakeCell metabolism, 2019-11, Vol.30 (5), p.987-996.e6 [Peer Reviewed Journal]Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved. ;2019 The Authors 2019 ;ISSN: 1550-4131 ;EISSN: 1932-7420 ;DOI: 10.1016/j.cmet.2019.07.013 ;PMID: 31447324Full text available |
|
19 |
Material Type: Article
|
Pharos: Collating protein information to shed light on the druggable genomeNucleic acids research, 2017-01, Vol.45 (D1), p.D995-D1002 [Peer Reviewed Journal]Published by Oxford University Press on behalf of Nucleic Acids Research 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US. ;Published by Oxford University Press on behalf of Nucleic Acids Research 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US. 2017 ;ISSN: 0305-1048 ;EISSN: 1362-4962 ;DOI: 10.1093/nar/gkw1072 ;PMID: 27903890Full text available |
|
20 |
Material Type: Article
|
Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5Obesity (Silver Spring, Md.), 2020-06, Vol.28 (6), p.1050-1061 [Peer Reviewed Journal]2020 The Authors. published by Wiley Periodicals, Inc. on behalf of The Obesity Society (TOS) ;2020 The Authors. Obesity published by Wiley Periodicals, Inc. on behalf of The Obesity Society (TOS). ;Copyright Blackwell Publishing Ltd. Jun 2020 ;ISSN: 1930-7381 ;EISSN: 1930-739X ;DOI: 10.1002/oby.22794 ;PMID: 32441473Full text available |